AVM BIOTECHNOLOGY
AVM is a clinical-stage biotech company located in Seattle WA led by Dr. Theresa Deisher, a biotech veteran with a productive history including 47 patents and 4 discoveries in clinical trials. The company's lead drug AVM0703, an innovative formulation of dexamethasone, when given at suprapharmacologic doses has a novel mechanism of action to mobilize the body's own natural supercharged immune cells. AVM0703 could be the first choice for no-option cancer, autoimmunity, and infectious disease. AVM Biotechnology has a Scientific Advisory Board including well-respected leaders in cancer and immunology.
AVM BIOTECHNOLOGY
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2008-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.avmbiotech.com
Total Employee:
11+
Status:
Active
Contact:
+1 206 906 9922
Email Addresses:
[email protected]
Total Funding:
24.35 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Current Employees Featured
Founder
Investors List
National Institutes of Health
National Institutes of Health investment in Grant - AVM Biotechnology
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Diabetes and Digestive and Kidney Diseases investment in Grant - AVM Biotechnology
National Institutes of Health (NIH)
National Institutes of Health (NIH) investment in Grant - AVM Biotechnology
Official Site Inspections
http://www.avmbiotech.com
- Host name: 150.152.196.35.bc.googleusercontent.com
- IP address: 35.196.152.150
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
